Skip to content
healthcare.dev
Get a free key

Ranolazine

NDC 60290-056, Ranolazine, tablet, extended release, from Umedica Laboratories USA Inc..

Product NDC
60290-056
Status
Listed
Labeler
Umedica Laboratories USA Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214551
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60290-056 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE1000 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
60290-056-016029000560160 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-056-01)
60290-056-03602900056036 BLISTER PACK in 1 CARTON (60290-056-03) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a624dc7f-921d-4554-a813-f72dca0133c3

Use it

Look up 60290-056 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60290-056 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60290-056. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.